Amsterdam UMC at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Amsterdam UMC brings 14 presentations to ASH 2026 in New Orleans. Its program spans lymphoma, myeloma, sickle cell disease and bleeding disorders, much of it clinical. It includes trial results on stopping and restarting ibrutinib-venetoclax in relapsed CLL.
| Organization | ASH 2026 Attendance |
|---|---|
Amsterdam UMC Amsterdam, Netherlands | |
Academic medical center in Amsterdam, Netherlands. | Oral Sat Dec 12 9:30am–11:00am Oral Sat Dec 12 2:00pm–3:30pm Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Oral Sun Dec 13 9:30am–11:00am Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 4:30pm–6:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Amsterdam UMC
Tell us what you sell and we’ll find the people at Amsterdam UMC most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction